Results 1 to 10 of about 820,790 (264)

Resistance to antibody–drug conjugates: A review

Acta Pharmaceutica Sinica B
Antibody–drug conjugates (ADCs) are antitumor drugs composed of monoclonal antibodies and cytotoxic payload covalently coupled by a linker. Currently, 15 ADCs have been clinically approved worldwide.
Sijia Li, Xinyu Zhao, Kai Fu, Shuangli Zhu, Can Pan, Chuan Yang, Fang Wang, Kenneth K.W. To, Liwu Fu   +8 more
doaj   +1 more source

Emergence of prions selectively resistant to combination drug therapy.

PLoS Pathogens, 2020
Prions are unorthodox infectious agents that replicate by templating misfolded conformations of a host-encoded glycoprotein, collectively termed PrPSc.
Cassandra M Burke, Kenneth M K Mark, Judit Kun, Kathryn S Beauchemin, Surachai Supattapone   +4 more
doaj   +1 more source

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS

Russian Journal of Cardiology, 2017
The article presents modern view on the role of combination antihypertension therapy in treatment of arterial hypertension. The benefits of fixed combinations are shown, rational combinations described for three antihypertensive medications. The results of investigations provided witnessing the increase of efficacy of antihypertension therapy with ...
O. D. Ostroumova, V. V. Vikentiev, T. F. Guseva   +2 more
openaire   +2 more sources

Artificial intelligence in drug combination therapy

Briefings in Bioinformatics, 2018
AbstractCurrently, the development of medicines for complex diseases requires the development of combination drug therapies. It is necessary because in many cases, one drug cannot target all necessary points of intervention. For example, in cancer therapy, a physician often meets a patient having a genomic profile including more than five molecular ...
openaire   +2 more sources

HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model

Drug Delivery, 2018
Multi-drug delivery systems, which may be promising solution to overcome obstacles, have limited the clinical success of multi-drug combination therapies to treat cancer.
Yi Gou, Zhenlei Zhang, Dongyang Li, Lei Zhao, Meiling Cai, Zhewen Sun, Yongping Li, Yao Zhang, Hamid Khan, Hongbing Sun, Tao Wang, Hong Liang, Feng Yang   +12 more
doaj   +1 more source

Customising the therapeutic response of signalling networks to promote antitumor responses by drug combinations

Frontiers in Oncology, 2014
Drug resistance, de novo and acquired, pervades cellular signalling networks from one signalling motif to another as a result of cancer progression and/or drug intervention.
Alexey eGoltsov, Simon eLangdon, Gregory eGoltsov, David eHarrison, James eBown   +4 more
doaj   +1 more source

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis

Bulletin of the World Health Organization, 2001
There is considerable exigency to take all necessary steps to cure tuberculosis cases and prevent further emergence of drug-resistant tuberculosis. The most important of these steps is to ensure that the treatment, particularly of sputum smear-positive ...
Blomberg Bjørn, Spinaci Sergio, Fourie Bernard, Laing Richard   +3 more
doaj  

Consumo de medicamentos por idosos, Goiânia, Brasil

Revista de Saúde Pública
OBJETIVO: Analisar o padrão de consumo de medicamentos entre idosos e sua associação com aspectos socioeconômicos e autopercepção de saúde. MÉTODOS: Estudo de base populacional e delineamento transversal com 934 idosos de Goiânia, GO, Brasil, entre ...
Thalyta Renata Araújo Santos, Dione Marçal Lima, Adélia Yaeko Kyosen Nakatani, Lílian Varanda Pereira, Geraldo Sadoyama Leal, Rita Goreti Amaral   +5 more
doaj  

Research Progress on Nano-Drug Delivery Systems for Photothermal Cancer Therapy

International Journal of Nanomedicine
Tao Li,1 Dan Xiao,2 Yanlong Yin,3 Liwen Hu4 1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Department of Pharmacy, Jiu Xing Nephrotic Hospital of Chengdu Wuhou, Chengdu, People’s Republic of China;
Li T, Xiao D, Yin Y, Hu L
doaj  

Research Strategies and Methods of Hydrogels for Antitumor Drug Delivery

Biomedicines
Tumor treatments have substantially advanced through various approaches, including chemotherapy, radiotherapy, immunotherapy, and gene therapy. However, efficient treatment necessitates overcoming physiological barriers that impede the delivery of ...
Tianjiao Zeng, Lusi Chen, Toru Yoshitomi, Naoki Kawazoe, Yingnan Yang, Guoping Chen   +5 more
doaj   +1 more source